Fukuda M - Search Results

1

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.

Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T. Hashizume R, et al. Among authors: fukuda m. J Biol Chem. 2001 May 4;276(18):14537-40. doi: 10.1074/jbc.C000881200. Epub 2001 Mar 6. J Biol Chem. 2001. PMID: 11278247 Free article.

2

In vitro ubiquitination of cyclin D1 by ROC1-CUL1 and ROC1-CUL3.

Maeda I, Ohta T, Koizumi H, Fukuda M. Maeda I, et al. Among authors: fukuda m. FEBS Lett. 2001 Apr 13;494(3):181-5. doi: 10.1016/s0014-5793(01)02343-2. FEBS Lett. 2001. PMID: 11311237 Free article.

3

[Cell cycle regulators as prognostic factors of breast cancers].

Ohta T, Fukuda M. Ohta T, et al. Among authors: fukuda m. Nihon Rinsho. 2000 Apr;58 Suppl:448-53. Nihon Rinsho. 2000. PMID: 11026032 Review. Japanese. No abstract available.

4

Analysis of Cdc2 and Cyclin D1 Expression in Breast Cancer by Immunoblotting.

Ohta T, Fukuda M, Arima K, Kawamoto H, Hashizume R, Arimura T, Yamaguchi S. Ohta T, et al. Among authors: fukuda m. Breast Cancer. 1997 Mar 25;4(1):17-24. doi: 10.1007/BF02967050. Breast Cancer. 1997. PMID: 11091571

5

Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen.

Fukuda M, Yamaguchi S, Ohta T, Nakayama Y, Ogata H, Shimizu K, Nishikawa T, Adachi Y, Fukuma E. Fukuda M, et al. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):77-81. Oncology (Williston Park). 1999. PMID: 10442369 Free article.

6

T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21.

Ohta T, Okamoto K, Isohashi F, Shibata K, Fukuda M, Yamaguchi S, Xiong Y. Ohta T, et al. Among authors: fukuda m. Cancer Res. 1998 Mar 15;58(6):1095-8. Cancer Res. 1998. PMID: 9515786

7

Behavior of the cell cycle-associated proteins in an unusual G0-arrestable cancer cell line.

Ohta T, Fukuda M, Wanebo HJ, Jogo K, Yamaguchi S. Ohta T, et al. Among authors: fukuda m. Exp Cell Res. 1996 May 25;225(1):85-92. doi: 10.1006/excr.1996.0159. Exp Cell Res. 1996. PMID: 8635520

8

Prospective evaluation of skin surface electropotentials in Japanese patients with suspicious breast lesions.

Fukuda M, Shimizu K, Okamoto N, Arimura T, Ohta T, Yamaguchi S, Faupel ML. Fukuda M, et al. Jpn J Cancer Res. 1996 Oct;87(10):1092-6. doi: 10.1111/j.1349-7006.1996.tb03115.x. Jpn J Cancer Res. 1996. PMID: 8957069 Free PMC article.

9

[A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].

Yamaguchi S, Fukuda M, Ota T, Nakayama Y, Ogata H, Shimizu K, Nishikawa T, Adachi Y, Fukuma E. Yamaguchi S, et al. Among authors: fukuda m. Gan To Kagaku Ryoho. 1999 Jul;26(8):1145-52. Gan To Kagaku Ryoho. 1999. PMID: 10431580 Clinical Trial. Japanese.

10

Elucidation of chemical compounds responsible for foot malodour.

Kanda F, Yagi E, Fukuda M, Nakajima K, Ohta T, Nakata O. Kanda F, et al. Among authors: fukuda m. Br J Dermatol. 1990 Jun;122(6):771-6. doi: 10.1111/j.1365-2133.1990.tb06265.x. Br J Dermatol. 1990. PMID: 2369557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,303 results

Search Page

Filters